| BEP | bleomycin, etoposide, and cisplatin |
| CAF | cancer-associated fibroblasts |
| ceRNA | competing endogenous RNA |
| CSC | cancer stem cells |
| EC | endometroid carcinoma |
| EMT | epithelial to mesenchymal transition |
| EOC | epithelial ovarian cancer |
| FIGO | Fédération Internationale de Gynécologie et d’Obstétrique |
| GCT | granulosa cell tumor |
| HGSOC | high-grade serous ovarian cancer |
| HOTAIR | HOX transcript antisense RNA |
| IOT | immature ovarian teratocarcinoma |
| LGSOC | low-grade serous ovarian cancer |
| lincRNA | long intergenic non-coding RNA |
| lncRNA | long non-coding RNA |
| MALAT1 | metastasis-associated lung adenocarcinoma transcript 1 |
| MSC | mesenchymal stem cell |
| MET | mesenchymal to epithelial transition |
| miRNA/miR | microRNA |
| MOC | mucinous ovarian carcinoma |
| NAT | natural antisense transcript |
| ncRNA | non-coding RNA |
| OC | ovarian cancer |
| OCCC | ovarian clear cell carcinoma |
| OCSC | ovarian cancer stem cells |
| PCOS | polycystic ovary syndrome |
| PRC | Polycomb Repressive Complex |
| RNAi | RNA interference |
| ROC | rare ovarian cancer |
| siRNA | small interfering RNA |
| shRNA | short hairpin RNA |
| XIST | X-inactive specific transcript |